Literature DB >> 25500500

Serotype 19A Bacteremic Pneumococcal Pneumonia After 4 Doses of 13-Valent Conjugate Vaccine: A Review of Pneumococcal Conjugate Vaccine Effectiveness.

Pui-Ying Iroh Tam1, Benjamin R Hanisch2, Brennan Forward2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 25500500      PMCID： PMC4465057          DOI： 10.1177/0009922814562550

Source DB:  PubMed          Journal:  Clin Pediatr (Phila)        ISSN： 0009-9228            Impact factor:   1.168


× No keyword cloud information.
  10 in total

1.  Vaccine epidemiology: efficacy, effectiveness, and the translational research roadmap.

Authors:  Geoffrey A Weinberg; Peter G Szilagyi
Journal:  J Infect Dis       Date:  2010-06-01       Impact factor: 5.226

2.  Parapneumonic pleural effusions caused by Streptococcus pneumoniae serotype 3 in children immunized with 13-valent conjugated pneumococcal vaccine.

Authors:  Charalampos Antachopoulos; Maria N Tsolia; Georgina Tzanakaki; Athanasia Xirogianni; Olga Dedousi; Georgia Markou; Sofia-Maria Zografou; Andreas Eliades; Fotis Kirvassilis; Konstantinos Kesanopoulos; Emmanuel Roilides
Journal:  Pediatr Infect Dis J       Date:  2014-01       Impact factor: 2.129

3.  Effectiveness of the new serotypes in the 13-valent pneumococcal conjugate vaccine.

Authors:  Elizabeth Miller; Nicholas J Andrews; Pauline A Waight; Mary P E Slack; Robert C George
Journal:  Vaccine       Date:  2011-10-05       Impact factor: 3.641

4.  Serotype 3 pneumococcal pleural empyema in an immunocompetent child after 13-valent pneumococcal conjugate vaccine.

Authors:  Fouad Madhi; Cécile Godot; Philippe Bidet; Mathilde Bahuaud; Ralph Epaud; Robert Cohen
Journal:  Pediatr Infect Dis J       Date:  2014-05       Impact factor: 2.129

5.  Severe Streptococcus pneumoniae 19A pneumonia with empyema in children vaccinated with pneumococcal conjugate vaccines.

Authors:  Chun-Yi Lu; Yung-Tien Ting; Li-Min Huang
Journal:  J Formos Med Assoc       Date:  2014-03-24       Impact factor: 3.282

6.  Use and interpretation of diagnostic vaccination in primary immunodeficiency: a working group report of the Basic and Clinical Immunology Interest Section of the American Academy of Allergy, Asthma & Immunology.

Authors:  Jordan S Orange; Mark Ballow; E Richard Stiehm; Zuhair K Ballas; Javier Chinen; Maite De La Morena; Dinakantha Kumararatne; Terry O Harville; Paul Hesterberg; Majed Koleilat; Sean McGhee; Elena E Perez; Jason Raasch; Rebecca Scherzer; Harry Schroeder; Christine Seroogy; Aarnoud Huissoon; Ricardo U Sorensen; Rohit Katial
Journal:  J Allergy Clin Immunol       Date:  2012-09       Impact factor: 10.793

7.  Serotype 19A Is the most common serotype causing invasive pneumococcal infections in children.

Authors:  Sheldon L Kaplan; William J Barson; Philana L Lin; Stephanie H Stovall; John S Bradley; Tina Q Tan; Jill A Hoffman; Laurence B Givner; Edward O Mason
Journal:  Pediatrics       Date:  2010-02-22       Impact factor: 7.124

8.  Safety, tolerability, and immunologic noninferiority of a 13-valent pneumococcal conjugate vaccine compared to a 7-valent pneumococcal conjugate vaccine given with routine pediatric vaccinations in Germany.

Authors:  Dorothee M Kieninger; Kathrin Kueper; Katrin Steul; Christine Juergens; Norbert Ahlers; Sherryl Baker; Kathrin U Jansen; Carmel Devlin; William C Gruber; Emilio A Emini; Daniel A Scott
Journal:  Vaccine       Date:  2010-04-22       Impact factor: 3.641

9.  Streptococcus pneumoniae serotype 19A bacteremia in a child fully immunized with 10-valent pneumococcal conjugate vaccine.

Authors:  Pak-Leung Ho; Maggie Y Chan; Kin-Hung Chow; Susan S Chiu
Journal:  J Microbiol Immunol Infect       Date:  2013-10-31       Impact factor: 4.399

10.  Preimmunization and postimmunization pneumococcal antibody titers in children with recurrent infections.

Authors:  H Hidalgo; C Moore; L E Leiva; R U Sorensen
Journal:  Ann Allergy Asthma Immunol       Date:  1996-04       Impact factor: 6.347
  10 in total
  1 in total

1.  A case report of parapneumonic pleural effusion caused by Streptococcus pneumoniae serotype 19A in a child immunized with 13-valent conjugate pneumococcal vaccine.

Authors:  Idrissa Diawara; Khalid Zerouali; Naima Elmdaghri; Abderrahman Abid
Journal:  BMC Pediatr       Date:  2017-04-27       Impact factor: 2.125
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.